In situ CAR engineering and nanoparticle-mediated TREM2 degradation for macrophage reprogramming in malignant ascites

Wait 5 sec.

Nature Materials, Published online: 06 November 2026; doi:10.1038/s41563-026-02769-2Targeted lipid nanoparticles reprogram TREM2+-tumour-associated macrophages in ascitic fluid into chimeric antigen receptor macrophage cells, providing an in situ cell engineering strategy that alters the tumour microenvironment and promotes tumour cell elimination in rodent models.